Overview

ED90 for Hyperbaric Bupivacaine in Super Obese Parturients

Status:
Recruiting
Trial end date:
2022-11-01
Target enrollment:
0
Participant gender:
Female
Summary
The aim of this study is to determine the ED90 of hyperbaric intrathecal bupivacaine for the super obese population undergoing cesarean section under a combined spinal epidural technique.
Phase:
Phase 4
Accepts Healthy Volunteers?
Accepts Healthy Volunteers
Details
Lead Sponsor:
Duke University
Treatments:
Bupivacaine
Criteria
Inclusion Criteria:

- American Society of Anesthesiology (ASA) class 2 and 3

- English speaking

- Gestational age > 36 weeks

- Scheduled for cesarean delivery under combined spinal epidural anesthesia

- 18 years or older

- BMI > 50 kg/m2

Exclusion Criteria:

- History of past or current intravenous drug or chronic opioid abuse

- Allergy or contraindication to any study medications

- Intrapartum cesarean delivery under epidural anesthesia

- Cesarean delivery under general anesthesia